Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

	Abstract	Full	Pdf
Feb 2022	1143	1164	392
Mar 2022	823	834	215
Apr 2022	415	435	158
May 2022	292	297	88
Jun 2022	156	165	51
Jul 2022	155	159	31
Aug 2022	175	179	78
Sep 2022	158	159	48
Oct 2022	156	163	59
Nov 2022	140	144	33
Dec 2022	112	121	30
Jan 2023	91	91	20
Feb 2023	108	109	52
Mar 2023	78	79	29
Apr 2023	67	68	45
May 2023	73	74	24
Jun 2023	103	104	20
Jul 2023	50	50	20
Aug 2023	41	43	20
Sep 2023	37	38	16
Oct 2023	30	30	18
Nov 2023	50	50	10
Dec 2023	64	66	27
Jan 2024	60	63	18
Feb 2024	52	52	27
Mar 2024	141	142	60
Total	4770	4879	1589